Organon Pharma Indonesia Tbk. vs Bank Woori Saudara Indonesia 1906 Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Bank Woori Saudara Indonesia 1906 Tbk. trades at Rp214 (market cap 3.11T, 1.92M 24h volume). The key difference: Bank Woori Saudara Indonesia 1906 Tbk. is far larger — about 29.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SDRA | |
|---|---|---|
Market Cap | 104.4B | 3.11T |
Volume | — | 1.92M |
Lot | — | 19.18K |
Turnover | — | 406.26M |
Average Price | — | 211.83 |
Value | — | 406.26M |
Indicative Equilibrium Price | — | 214 |
Indicative Equilibrium Volume | — | 5 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Bank Woori Saudara Indonesia 1906 Tbk(the Bank)(formerly PT Bank Himpunan Saudara 1906) was established under its original name of Perkumpulan Himpunan Saudara on 1906 then at 11 Nov 1955 the Company has been licensed as Saving Bank. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Meiyane, S.H., dated Apr 26, 2006, concerning company public offering. On December 24, 2014 the Extraordinary Shareholders Meeting Approved the change of name into PT Bank Woori Saudara Indonesia 1906 Tbk.
Read more on SDRA →